COMMUNICATIONS FOR HEALTH APPLICATIONS AND INTERVENTIONS The Communications for Health Applications and Interventions (CHAI) SR provides tremendous value and service to the Center through its development of modern communication techniques for the range of implementation, clinical, prevention and control research. The services available include behavioral e- and m- health interventions, qualitative and software design services using adaptive technology. Services for faculty research projects include: responsive web application, device integration, geofencing, user experience (UX) and qualitative survey development. The SR was used by more than 30 faculty in fiscal year 2019 which represented 82% of the total users. CHAI requests $139,365 of a total operating budget of $959,660. The Center ensure cost-effectiveness and value to the membership through a sustained annual contribution of approximately $310,000. It is well integrated within the LCCC programs contributed to key studies including: ? PRO-PM: a qualitative study designed to understand patient, caregiver and provider perceptions on patient reported outcomes during chemotherapy. CHAI supported the research through creation of interview guides and conduct of over 100 one on one interviews with adult patients receiving chemotherapy, healthcare administrators, health service researchers, clinicians, and patient advocates across six cancer centers nationwide. ? PERC: a mixed method study to evaluate feasibility and acceptability of a web based, couple-focused intervention on prostate cancer symptom management, quality of life and psychosocial factors. CHAI hosted the web site and supported data collection though a built-in automatic tracking system for times logged in, time spent on site. ? COMET: a 5 year PCORI-funded project, will involve 1200 patients. The goal of the COMET (Comparison of Operative vs Monitoring and Endocrine Therapy) trial for low-risk ductal carcinoma in situ (DCIS). CHAI contributed to the creation of a responsive website that provide accessible, understandable, and evidence-based information about DCIS, treatment options, including the trade- offs of each treatment option. The 9 person CHAI SR includes experts in qualitative analysis, software development graphic design and project management. CHAI is directed by Deborah Tate, PhD a nationally recognized expert in communications and behavioral science. The SR uses multiple techniques to test the efficacy of e- or m- messaging and is careful to assess changes in communication usage for example that many in rural areas have restricted access to broadband yet higher penetration through mobile devices. Integration with Community Outreach and Engagement is key in the development of CHAI methods.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089835
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Spencer, Jennifer C; Brewer, Noel T; Trogdon, Justin G et al. (2018) Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients. Am J Public Health 108:946-950
Hu, Jiemiao; Sun, Chuang; Bernatchez, Chantale et al. (2018) T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors. Clin Cancer Res 24:2920-2934
DeKroon, Robert M; Gunawardena, Harsha P; Edwards, Rachel et al. (2018) Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. MBio 9:
Bailey, Rachel M; Armao, Diane; Nagabhushan Kalburgi, Sahana et al. (2018) Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy. Mol Ther Methods Clin Dev 9:160-171
Liu, E; Tong, Y; Dotti, G et al. (2018) Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. Leukemia 32:520-531
Chao, Yvonne L; Pecot, Chad V (2018) Immunotherapy combinations emerging in non-small-cell lung cancer. Immunotherapy 10:627-629
Braithwaite, Dejana; Miglioretti, Diana L; Zhu, Weiwei et al. (2018) Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. JAMA Intern Med 178:494-501
Dusetzina, Stacie B; Huskamp, Haiden A; Winn, Aaron N et al. (2018) Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws. JAMA Oncol 4:e173598
Smith, Collin-Jamal; Allard, Denise E; Wang, Yan et al. (2018) IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration. J Immunol 200:1580-1592
Montgomery, Nathan D; Tomoka, Tamiwe; Krysiak, Robert et al. (2018) Practical Successes in Telepathology Experiences in Africa. Clin Lab Med 38:141-150

Showing the most recent 10 out of 1525 publications